Sam Hollingworth

Dr. Sam Hollingworth is an Honorary Senior Lecturer at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland, with visiting appointments at Imperial College London and Kwame Nkrumah University of Science and Technology. Their research focuses on Health Technology Assessment (HTA), Pharmacoepidemiology, and Health Systems in low- and middle-income countries.

• BSc(Hons) and MPH from University of Queensland
• PhD from Monash University

Research Interests:

• Health Technology Assessment and evidence-informed decision-making
• Economic evaluations in healthcare
• Medicines use in populations (pharmacoepidemiology)
• Health systems for non-communicable diseases (NCDs)
• Implementation science

Recent Research Trends: Analysis of real-world medicine effectiveness, HTA capacity in sub-Saharan Africa, and antimicrobial stewardship across primary care professions.

Funding History: Grants from Metro South Hospital and Health Service, Department of Health and Ageing, UQ New Staff Research Fund, and NHMRC Centres of Research Excellence (2010-2018).

Supervision: Advisor for PhD projects on topics including antidepressant treatment discontinuation, patient-based benefit-risk assessment, and prescription opioid trends.

Collaborative Networks: Extensive partnerships in Ghana, Indonesia, and Australia for projects spanning non-communicable diseases, health equity, and medicine safety.